W*USA 9 [1] |
Novo touts one-year data for its diabetes tandem therapy [2]
FierceBiotech Combine the blockbuster GLP-1 drug Victoza with a long-acting insulin and you get a treatment greater than the sum of its parts, according to Novo Nordisk ($NVO), which unveiled promising new data on its diabetes cocktail IDegLira. In a 52-week study … Sanofi, Medtronic Form Diabetes Alliance [3]Wall Street Journal Sanofi, Medtronic join on diabetes drugs, devices [1]W*USA 9 Medtronic, Sanofi Join On Diabetes Drugs, Devices [4]CBS Local GlobeNewswire (press release) [5] all 105 news articles » [6] |
More details can be found at www.diabeteshowto.com [7]